Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04395911 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
A NA study, sponsored by SeaStar Medical.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04395911 is a NA study that has completed, run by SeaStar Medical. The registered enrollment target is 22 participants.
The verdict
NCT04395911, a NA study, has completed, sponsored by SeaStar Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.
Interventions
- DEVICE SCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2021-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04395911
The ClinicalTrials.gov registry entry for NCT04395911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SeaStar Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCD is the first listed.
NCT04395911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04395911 about?
NCT04395911 is a clinical study titled "Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections". Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.
What is the current status of trial NCT04395911?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-09-10. Estimated completion is 2021-07-21.
What interventions are being tested in trial NCT04395911?
The interventions under investigation include: SCD (DEVICE).
Who is sponsoring clinical trial NCT04395911?
This trial is sponsored by SeaStar Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.